Artios Pharma Investor

Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.

Invests into

Technology: AgeTech Companies
Industry: Healthcare
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2016-01-01
Employees Number: 101-250
Funding Status: Late Stage Venture
Estimated Revenue: $10M to $50M
Visit Website
info@artiospharma.com
https://twitter.com/artiospharma
Register and Claim Ownership